1921
Volume 91, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Administering primaquine (PQ) to treat malaria patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency can pose a serious risk of drug-induced hemolysis (DIH). New easy to use point-of-care rapid diagnostic tests are being developed as an alternative to labor-intensive spectrophotometric methods, but they require field testing before they can be used at scale. This study screened 456 participants in Gressier, Haiti using the Access Bio CareStart qualitative G6PD rapid detection test compared with the laboratory-based Trinity Biotech quantitative spectrophotometric assay. Findings suggest that the CareStart test was 90% sensitive for detecting individuals with severe deficiency and 84.8% sensitive for detecting individuals with moderate and severe deficiency compared with the Trinity Biotech assay. A high negative predictive value of 98.2% indicates excellent performance in determining those patients able to take PQ safely. The CareStart G6PD test holds much value for screening malaria patients to determine eligibility for PQ therapy.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0100
2014-07-02
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/1/77.html?itemId=/content/journals/10.4269/ajtmh.14-0100&mimeType=html&fmt=ahah

References

  1. Beutler E, , 2008. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111: 1624.[Crossref]
  2. Cappellini MD, Fiorelli G, , 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 6474.[Crossref]
  3. Beutler E, , 1996. G6PD: population genetics and clinical manifestations. Blood Rev 10: 4552.[Crossref]
  4. World Health Organization, 2010. World Malaria Report 2012. Available at: http://www.who.int/malaria/publications/world_malaria_report_2012/report/en/index.html. Accessed March 22, 2013.
  5. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, Baird K, Moyes C, Howes R, Menard D, Bancone G, Winasti-Satyahraha A, Vstergaard LSL, Green J, Domingo G, Yeung S, Price R, , 2013. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J 12: 112.[Crossref]
  6. Centers for Disease Control and Prevention, 2010. Malaria in Post-Earthquake Haiti: CDC's Recommendations for Prevention and Treatment. Available at: http://www.cdc.gov/malaria/new_info/2010/malaria_in_haiti_rec_pandt.html. Accessed July 17, 2013.
  7. von Fricken ME, Weppelmann TA, Eaton WT, Alam MT, Carter TE, Schick L, Masse R, Romain JR, Okech BA, , 2014. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti. Acta Trop 135: 6266.[Crossref]
  8. Nadarajan V, Shanmugam H, Sthaneshwar P, Jayaranee S, Sultan KS, Ang C, Arumugam S, , 2011. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)- deficient heterozygote female newborns. Int J Lab Hematol 33: 463470.
  9. De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, Ssemmondo E, Gonahasa S, Tumwebaze P, Diliberto D, Maiteki-Sebuguzi C, Staedke SG, Drakeley C, , 2013. Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar J 12: 210.[Crossref]
  10. World Health Organization Working Group, 1989. Glucose-6-phosphate dehydogenase deficiency. Bull World Health Organ 67: 601611.
  11. Kuwahata M, Wijesinghe R, Ho MF, Pelecanos A, Bobogare A, Landry L, Bugora H, Vallely A, McCarthy J, , 2010. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J 9: 223.[Crossref]
  12. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, , 2009. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42: 267278.[Crossref]
  13. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, Taylor WR, Baird JK, Menard D, , 2011. Performance of the CareStart G6PD Deficiency Screening Test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 6: e28357.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0100
Loading
/content/journals/10.4269/ajtmh.14-0100
Loading

Data & Media loading...

  • Received : 13 Feb 2014
  • Accepted : 21 Mar 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error